“Each of these mutations teach us something, and point to a particular gene as a potential target for new and more effective pain medications,” said Dr. Stephen G. Waxman, a neurologist at Yale, told the New York Times.

The hope is that discoveries like these lead to better treatments for chronic pain, which affects about 50 million U.S. adults and is often the reason people become addicted to opioids. Scientists also plan to investigate how Cameron’s wounds seem to heal quickly and leave little scarring.